Enpresse–28
Phase I
levonorgestrel 0.05 mg + ethinyl estradiol 30 mcg
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., et al. "Enpresse–28." Davis's Drug Guide, 19th ed., F.A. Davis Company, 2025. Emergency Central, emergency.unboundmedicine.com/emergency/view/Davis-Drug-Guide/109898/all/Enpresse–28.
Vallerand AHA, Sanoski CAC, . Enpresse–28. Davis's Drug Guide. F.A. Davis Company; 2025. https://emergency.unboundmedicine.com/emergency/view/Davis-Drug-Guide/109898/all/Enpresse–28. Accessed January 24, 2025.
Vallerand, A. H., Sanoski, C. A., & , (2025). Enpresse–28. In Davis's Drug Guide (19th ed.). F.A. Davis Company. https://emergency.unboundmedicine.com/emergency/view/Davis-Drug-Guide/109898/all/Enpresse–28
Vallerand AHA, Sanoski CAC, . Enpresse–28 [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2025. [cited 2025 January 24]. Available from: https://emergency.unboundmedicine.com/emergency/view/Davis-Drug-Guide/109898/all/Enpresse–28.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Enpresse–28
ID - 109898
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
AU - ,,
BT - Davis's Drug Guide
UR - https://emergency.unboundmedicine.com/emergency/view/Davis-Drug-Guide/109898/all/Enpresse–28
PB - F.A. Davis Company
ET - 19
DB - Emergency Central
DP - Unbound Medicine
ER -